STUDY OF CLINICAL CHARACTERISTICS AND SOME FACTORS RELATED TO THE SEVERITY OF LESIONS IN PATIENTS WITH PSORIASIS AND DYSLIPIDEMIA
Main Article Content
Abstract
Introduction: Dyslipidemia is a common comorbidity in psoriasis. Preliminary studies have evaluated the clinical characteristics of psoriasis patients with concomitant dyslipidemia. However, in Vietnam, research on this topic remains limited. Objective: To describe the clinical characteristics and some factors associated with the severity of lesions in psoriasis patients with concomitant dyslipidemia. Methods: A cross-sectional descriptive study was conducted on patients with plaque psoriasis and dyslipidemia visiting Can Tho Dermatology Hospital from June 2023 to May 2024. Results: A total of 50 patients were included, with 44.0% being female. The most common symptom was itching (58.0%), with female patients reporting itching more frequently than males. The most common sites of involvement were the head, neck, and trunk (76.0% each). There was a significant association between the severity of lesions and factors such as overweight/obesity and prolonged use of topical corticosteroids. Conclusion: Itching is the most common symptom in psoriasis patients with concomitant dyslipidemia. Overweight and obese individuals tend to have more severe skin lesions compared to those with normal weight.
Article Details
Keywords
Psoriasis, dyslipidemia, clinical characteristics, severity of lesions
References

2. Yosipovitch G, et al. The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. British Journal of Dermatology. 2000. 143(5), p. 969-973.

3. Nakhwa Y, et al. Dyslipidemia in psoriasis: a case controlled study. International scholarly research notices. 2014. 2014(1), p. 729157.

4. Bộ Y Tế. Hướng dẫn chẩn đoán và điều trị các bệnh da liễu. Quyết định số 75/QĐ-BYT ngày 13 tháng 01 năm 2015, tr. 161-166.

5. Eckel RH, et al. Update on the NCEP ATP-III emerging cardiometabolic risk factors. BMC medicine. 2014. 12(1), p. 1-9.

6. Kubanov A, et al. PASI (Psoriasis Area and Severity Index) in the evaluation of the clinical manifestations of psoriasis. Vestnik dermatologii i venerologii. 2016. 92(4), p. 33-38.

7. Bardazzi F, et al. Correlation between BMI and PASI in patients affected by moderate to severe psoriasis undergoing biological therapy. Dermatologic therapy. 2010. 23(1), p. S14-S19.

8. Fleming P, et al. The relationship of obesity with the severity of psoriasis: a systematic review. Journal of cutaneous medicine and surgery. 2015. 19(5), p. 450-456.
